Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas

Hezhe Lu; Shujing Liu; Gao Zhang; Bin Wu; Yueyao Zhu; Dennie T Frederick; Yi Hu; Wenqun Zhong; Sergio Randell; Norah Sadek; Wei Zhang; Gang Chen; Chaoran Cheng; Jingwen Zeng; Lawrence W Wu; Jie Zhang; Xiaoming Liu; Wei Xu; Clemens Krepler; Katrin Sproesser; Min Xiao; Benchun Miao; Jianglan Liu; Claire D Song; Jephrey Y Liu; Giorgos C Karakousis; Lynn M Schuchter; Yiling Lu; Gordon Mills; Yusheng Cong; Jonathan Chernoff; Jun Guo; Genevieve M Boland; Ryan J Sullivan; Zhi Wei; Jeffrey Field; Ravi K Amaravadi; Keith T Flaherty; Meenhard Herlyn; Xiaowei Xu; Wei Guo

doi:10.1038/s41586-018-0814-7

Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas

Nature. 2019 Jan;565(7738):E4. doi: 10.1038/s41586-018-0814-7.

Authors

Hezhe Lu^#¹, Shujing Liu^#², Gao Zhang^#³, Bin Wu¹, Yueyao Zhu¹, Dennie T Frederick⁴, Yi Hu⁵, Wenqun Zhong¹, Sergio Randell³, Norah Sadek³, Wei Zhang¹, Gang Chen¹, Chaoran Cheng⁶, Jingwen Zeng¹, Lawrence W Wu³, Jie Zhang⁶, Xiaoming Liu², Wei Xu⁷, Clemens Krepler³, Katrin Sproesser³, Min Xiao³, Benchun Miao⁴, Jianglan Liu³, Claire D Song¹, Jephrey Y Liu⁷, Giorgos C Karakousis⁸, Lynn M Schuchter⁷, Yiling Lu⁹, Gordon Mills⁹, Yusheng Cong¹⁰, Jonathan Chernoff¹¹, Jun Guo¹², Genevieve M Boland¹³, Ryan J Sullivan⁴, Zhi Wei⁶, Jeffrey Field¹⁴, Ravi K Amaravadi⁸, Keith T Flaherty⁴, Meenhard Herlyn^#¹⁵, Xiaowei Xu^#^{16

17}, Wei Guo^#¹⁸

Affiliations

¹ Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
² Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
³ Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, 19104, USA.
⁴ Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, USA.
⁵ Department of Biology, Drexel University, Philadelphia, Pennsylvania, 19104, USA.
⁶ Department of Computer Science, New Jersey Institute of Technology, Newark, New Jersey, 07102, USA.
⁷ Abramson Cancer Center and Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
⁸ Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
⁹ Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77054, USA.
¹⁰ Institute of Aging Research, Hangzhou Normal University School of Medicine, Hangzhou, China.
¹¹ Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, USA.
¹² Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100036, China.
¹³ Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA.
¹⁴ Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
¹⁵ Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, 19104, USA. [email protected].
¹⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA. [email protected].
¹⁷ Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA. [email protected].
¹⁸ Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA. [email protected].

^# Contributed equally.

PMID: 30532003
DOI: 10.1038/s41586-018-0814-7

Abstract

In this Letter, two relevant references were omitted; see the accompanying Amendment for details. The original Letter has not been corrected.

Publication types

Published Erratum